Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Antibiotics for pre-term pre-labour rupture of membranes: Prevention of neonatal deaths due to complications of pre-term birth and infection
International Journal of Epidemiology, Volume 39, No. SUPPL. 1, Year 2010
Notification
URL copied to clipboard!
Description
Background: In high-income countries, it is standard practice to give antibiotics to women with pre-term, pre-labour rupture of membranes (pPROM) to delay birth and reduce the risk of infection. In low and middle-income settings, where some 2 million neonatal deaths occur annually due to complications of pre-term birth or infection, many women do not receive antibiotic therapy for pPROM. Objectives: To review the evidence for and estimate the effect on neonatal mortality due to pre-term birth complications or infection, of administration of antibiotics to women with pPROM, in low and middle-income countries. Methods: We performed a systematic review to update a Cochrane review. Standardized abstraction forms were used. The quality of the evidence provided by individual studies and overall was assessed using an adapted GRADE approach. Results: Eighteen RCTs met our inclusion criteria. Most were from high-income countries and provide strong evidence that antibiotics for pPROM reduce the risk of respiratory distress syndrome [risk ratio (RR)=0.88; confidence interval (CI) 0.80, 0.97], and early onset postnatal infection (RR=0.61; CI 0.48, 0.77). The data are consistent with a reduction in neonatal mortality (RR=0.90; CI 0.72, 1.12). Conclusion: Antibiotics for pPROM reduce complications due to pre-term delivery and post-natal infection in high-income settings. There is moderate quality evidence that, in low-income settings, where access to other interventions (antenatal steroids, surfactant therapy, ventilation, antibiotic therapy) may be low, antibiotics for pPROM could prevent 4% of neonatal deaths due to complications of prematurity and 8% of those due to infection. © The Author 2010; all rights reserved.
Authors & Co-Authors
Cousens, Simon Nicholas
Unknown Affiliation
Blencowe, Hannah K.
Unknown Affiliation
Gravett, Michael G.
Unknown Affiliation
Lawn, Joy E.
Unknown Affiliation
Statistics
Citations: 4
Authors: 4
Affiliations: 5
Identifiers
Doi:
10.1093/ije/dyq030
ISSN:
03005771
e-ISSN:
14643685
Research Areas
Health System And Policy
Maternal And Child Health
Study Design
Randomised Control Trial
Study Approach
Systematic review
Participants Gender
Female